The diagnosis and treatment of women has traditionally been based on research conducted on men. An increasing number of doctors are now calling for greater attention to be paid to gender-sensitive care, and for a greater focus on the differences between men and women with heart problems.
Jolanda van der Velden of VUmc, head of the Institute for Cardiovascular Research in the O|2 Lab building has this to say on the subject of ‘from bench to bedside’ research at O|2:
“Our basic research in the O|2 Lab building takes us inside the cell, including myocardial cells. In the clinic, interventional cardiologist Yolande Appelman picked up on signals that women with heart problems exhibit different symptoms than men. In men, the problems are often in the larger blood vessels. We then discovered in the lab that women tend to have more problems in the small vessels, resulting in diastolic heart failure. Problems experience by patients at the clinic lead to lab research, and our discoveries in the lab take us back to the clinic. It’s a bit like a rally in a tennis match. Working together to arrive at a solution.”
“So, where clinic and laboratory meet (VUmc-O|2), we are able to utilize new and innovative research methods to find new treatments for women with heart failure.”